3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
239
Sarcoma
10
Gastrointestinal
7
Dermatologic
7
Thoracic
6
Other hematologic neoplasm
6
Lymphoid
6
Endocrine
5
Head & Neck
4
Plasma cell
2
NET
2
Myeloid
2
Gynecologic
2
Genitourinary
2
Breast
2
Classical hematology
1
Conditions
Neuroendocrine Tumors
111
Gastro-enteropancreatic neuroendocrine tumor
19
Carcinoma, Neuroendocrine
12
Stomach Neoplasms
11
Pancreatic Neoplasms
10
Neoplasms
10
Breast Neoplasms
10
Pheochromocytoma
9
Carcinoid Tumor
9
Prostatic Neoplasms
8
Paraganglioma
8
Neoplasm Metastasis
8
Carcinoma, Hepatocellular
8
Adenoma, Islet Cell
8
Thyroid Neoplasms
7
Sarcoma
7
Gastrointestinal Neoplasms
7
Esophageal Neoplasms
7
Colorectal Neoplasms
7
Lung Neoplasms
6
Rectal Neoplasms
5
Ovarian Neoplasms
5
Neuroblastoma
5
Melanoma
5
Liver Neoplasms
5
Colonic Neoplasms
5
Anus Neoplasms
5
Uterine Cervical Neoplasms
4
Gastrointestinal Stromal Tumors
4
Cholangiocarcinoma
4
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Glioma
×
NET
×
Clear all
NCT06607692
2026-04-14
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled